Shosaku Nomura Selected Research

Shosaku Nomura Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 01/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 11/2002
16	Type 2 Diabetes Mellitus (MODY) 01/2018 - 05/2003
15	Multiple Myeloma 01/2022 - 04/2014
15	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 07/2002
13	Thrombosis (Thrombus) 07/2020 - 10/2005
12	Lung Neoplasms (Lung Cancer) 02/2019 - 01/2002
11	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 07/2005
9	Atherosclerosis 01/2015 - 11/2003
8	Hypertension (High Blood Pressure) 01/2016 - 04/2004
7	Rheumatoid Arthritis 01/2021 - 11/2012
6	Hemorrhage 01/2021 - 07/2002
6	Thrombocytopenia (Thrombopenia) 01/2012 - 07/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2003
5	Exanthema (Rash) 12/2020 - 04/2006
5	Inflammation (Inflammations) 11/2019 - 12/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 02/2004
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2014 - 03/2009
4	Infections 09/2022 - 03/2004
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2005
4	Disseminated Intravascular Coagulation 01/2018 - 01/2011
4	Lymphoma (Lymphomas) 01/2017 - 01/2002
4	Hyperlipidemias (Hyperlipidemia) 01/2012 - 05/2003
4	Hyperglycemia 01/2011 - 04/2004
3	Asthma (Bronchial Asthma) 01/2022 - 08/2019
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2020 - 01/2011
3	Colitis 10/2018 - 10/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2011
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2017 - 04/2007
3	Vascular System Injuries 11/2009 - 01/2008
3	Acute Coronary Syndrome 01/2009 - 03/2003
3	Stable Angina 12/2006 - 03/2003
2	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 12/2017
2	Pneumonia (Pneumonitis) 02/2022 - 06/2020
2	Arthritis (Polyarthritis) 01/2021 - 06/2011
2	Essential Thrombocythemia 07/2020 - 08/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2020 - 09/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2019 - 09/2017
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 05/2018

Drug/Important Bio-Agent (IBA)

15	RV 538 (PDMP)IBA 01/2019 - 02/2003
13	AdiponectinIBA 12/2015 - 09/2005
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2013
12	SelectinsIBA 01/2018 - 02/2003
11	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
11	Inosine Triphosphate (ITP)IBA 01/2021 - 07/2002
10	P-SelectinIBA 01/2018 - 07/2002
10	ChemokinesIBA 09/2009 - 11/2002
8	Chemokine CCL5IBA 11/2014 - 07/2002
7	Monoclonal AntibodiesIBA 01/2021 - 08/2003
7	oxidized low density lipoproteinIBA 03/2009 - 05/2003
6	AutoantibodiesIBA 01/2021 - 02/2009
6	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 07/2005
6	Rituximab (Mabthera)FDA Link 12/2017 - 04/2007
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2010
5	Pharmaceutical PreparationsIBA 07/2020 - 07/2005
5	Therapeutic UsesIBA 08/2019 - 05/2004
5	Bortezomib (Velcade)FDA Link 01/2019 - 01/2012
5	Cell Adhesion MoleculesIBA 09/2009 - 05/2003
4	Peptides (Polypeptides)IBA 01/2020 - 07/2002
4	Dasatinib (BMS 354825)FDA Link 01/2019 - 12/2017
4	Tyrosine Kinase InhibitorsIBA 01/2019 - 11/2011
4	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 04/2014
4	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2008
4	Dacarbazine (DIC)FDA LinkGeneric 01/2018 - 03/2004
4	Hemostatics (Antihemorrhagics)IBA 01/2018 - 01/2008
4	Eicosapentaenoic AcidIBA 01/2018 - 05/2003
4	Bevacizumab (Avastin)FDA Link 05/2017 - 12/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 04/2004
4	2- (4- methyl- 2,6- dinitroanilino)- N- methylpropionamide (MDMP)IBA 09/2009 - 02/2003
4	E-SelectinIBA 09/2009 - 05/2003
4	CD40 Ligand (CD40L)IBA 09/2009 - 11/2002
3	tocilizumab (atlizumab)FDA Link 01/2021 - 06/2011
3	CytokinesIBA 01/2021 - 01/2002
3	SteroidsIBA 01/2021 - 12/2010
3	mogamulizumabIBA 12/2020 - 02/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2005
3	Lipopolysaccharide ReceptorsIBA 01/2020 - 10/2003
3	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2011
3	NivolumabIBA 08/2018 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 05/2017 - 03/2013
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2009 - 09/2005
3	Gefitinib (Iressa)FDA Link 11/2006 - 10/2005
3	Annexin A5IBA 09/2005 - 05/2003
2	Antiviral Agents (Antivirals)IBA 09/2022 - 01/2010
2	eltrombopag FDA Link 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 07/2013
2	pomalidomideIBA 11/2020 - 05/2018
2	anagrelide (Agrylin)FDA LinkGeneric 07/2020 - 08/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 02/2019 - 08/2018

Therapy/Procedure

38	Therapeutics 01/2022 - 07/2002
18	Drug Therapy (Chemotherapy) 12/2019 - 01/2002
11	Stem Cell Transplantation 01/2021 - 01/2002
9	Hematopoietic Stem Cell Transplantation 09/2022 - 01/2012
4	Percutaneous Coronary Intervention 05/2010 - 10/2005
3	Aftercare (After-Treatment) 08/2018 - 02/2004
3	Transplantation 08/2015 - 01/2002
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2014